Skip to main content
Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).
Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group.
Clinical features and outcomes of infants with Ewing sarcoma under 12 months of age.
Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.
Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings.
Repeat blood cultures in children with persistent fever and neutropenia: Diagnostic and clinical implications.
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.
A pediatric case of T-cell prolymphocytic leukemia.
Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.